X/NN
chromosome/NN
inactivation/NN
patterns/NNS
in/IN
normal/JJ
females/NNS
./.

Since/IN
one/CD
of/IN
the/DT
two/CD
X/NN
chromosomes/NNS
is/VBZ
randomly/RB
inactivated/VBN
at/IN
an/DT
early/JJ
stage/NN
of/IN
female/NN
embryonic/JJ
development/NN
,/,
X-linked/JJ
markers/NNS
have/VBP
been/VBN
used/VBN
to/TO
study/VB
the/DT
origin/NN
and/CC
development/NN
of/IN
various/JJ
neoplastic/JJ
disorders/NNS
in/IN
affected/VBN
heterozygous/JJ
women/NNS
;/:
clonality/NN
assays/NNS
have/VBP
provided/VBN
a/DT
useful/JJ
tool/NN
to/TO
the/DT
understanding/NN
of/IN
the/DT
mechanisms/NNS
underlying/VBG
the/DT
development/NN
of/IN
neoplasia/NN
./.
=====
Recently/RB
,/,
a/DT
technique/NN
of/IN
clonal/JJ
analysis/NN
has/VBZ
been/VBN
devised/VBN
that/WDT
takes/VBZ
advantage/NN
of/IN
a/DT
highly/RB
polymorphic/JJ
short/JJ
tandem/JJ
repeat/NN
within/IN
the/DT
X-linked/JJ
human/JJ
androgen/NN
receptor/NN
(/(
AR/NN
)/)
gene/NN
,/,
resulting/VBG
in/IN
a/DT
heterozygosity/NN
rate/NN
approaching/VBG
90/CD
%/NN
./.
=====
The/DT
rapid/JJ
expansion/NN
of/IN
the/DT
number/NN
of/IN
women/NNS
now/RB
suitable/JJ
for/IN
X/NN
inactivation/NN
analysis/NN
has/VBZ
however/RB
given/VBN
rise/NN
to/TO
new/JJ
controversies/NNS
,/,
one/CD
of/IN
the/DT
more/RBR
troublesome/JJ
being/VBG
the/DT
possibility/NN
of/IN
a/DT
modification/NN
of/IN
the/DT
pattern/NN
of/IN
X- chromosome/NN
inactivation/NN
pattern/NN
in/IN
blood/NN
cells/NNS
of/IN
elderly/JJ
women/NNS
./.
=====
In/IN
the/DT
present/JJ
study/NN
we/PRP
analyze/VBP
with/IN
the/DT
AR/NN
assay/NN
a/DT
group/NN
of/IN
166/CD
healthy/JJ
females/NNS
aged/JJ
between/IN
8/CD
and/CC
94/CD
years/NNS
,/,
with/IN
no/DT
history/NN
of/IN
genetic/JJ
or/CC
neoplastic/JJ
familial/JJ
disorders/NNS
./.
=====
We/PRP
failed/VBD
to/TO
find/VB
any/DT
correlation/NN
between/IN
age/NN
and/CC
X- chromosome/NN
inactivation/NN
pattern/NN
(/(
r/NN
=/JJ
0.17/CD
)/)
,/,
even/RB
subdividing/VBG
the/DT
subjects/NNS
in/IN
different/JJ
age/NN
groups/NNS
according/VBG
to/TO
the/DT
criteria/NNS
used/VBN
by/IN
other/JJ
researchers/NNS
,/,
and/CC
therefore/RB
reaffirm/VBP
that/IN
,/,
when/WRB
tested/VBN
for/IN
with/IN
well-standardized/JJ
and/CC
accurate/JJ
criteria/NNS
,/,
extremely/RB
unbalanced/JJ
inactivation/NN
of/IN
the/DT
X/NN
chromosome/NN
is/VBZ
a/DT
truly/RB
uncommon/JJ
phenomenon/NN
in/IN
normal/JJ
women/NNS
./.
=====
Copyright/NN
1998/CD
Academic/NNP
Press/NNP
./.